kras mutation and glutathion BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress promotes site-specific metastasis by stimulating glutathione synthesis: Cell Reports Uncovering new therapeutic targets for
Uncovering new therapeutic targets for a common KRAS mutation behind cancer The KRAS G12D mutation induces metabolic vulnerability in B cell acute lymphoblastic leukemia ScienceDirect KRAS targeted therapies in cancer: novel approaches and overcoming resistance BMJ Oncology Kinetic and Redox Characterization of KRAS G12C Inhibition bioRxiv KRAS in Non Small Cell Lung Cancer Encyclopedia MDPI
Pay in 4 interest-free payments of $6.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13




